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ABSTRACT 15 
 Presentation for pruritus comprised 2.2 per cent of cat and 3.8 per cent of dog consultations, 16 
between January and April 2018.  17 
 The dorsal parts of the body were the most frequent location for pruritus in cats (27 cent). In dogs, 18 
pruritus most commonly affected the ear (37 per cent).  19 
 Pseudomonas aeruginosa antimicrobial susceptibility data was available from 37,673 clinical 20 
canine isolates, and 1,830 clinical feline isolates. Where a sampling site was recorded, ears were 21 
the most commonly recorded site for dogs (71.1 per cent of P. aeruginosa isolates), whereas 22 
oronasal samples were most common in the cat (36.6 per cent).  23 
 For dogs, 65.4 per cent of P. aeruginosa isolates were sensitive to all tested antimicrobials; and 24 
for cats 72.6 per cent. Tested isolates were most commonly resistant to fluoroquinolones in both 25 
dogs (25.0 per cent of tested isolates) and cats (17.7 per cent). Five canine isolates were found to 26 
be resistant to all tested antimicrobials; no such isolates were found in cats.   27 
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About this report 28 
This report is the sixth in a series by the Small Animal Veterinary Surveillance Network (SAVSNET).   29 
In the first section, we focus on surveillance for pruritus in the SAVSNET network of veterinary 30 
practices and present both the overall prevalence and the spatial distribution of pruritus across GB, 31 
from April 2017 to April 2018. Next, we describe confirmed cases of Pseudomonas infections using 32 
data collected by SAVSNET from collaborating veterinary laboratories across the UK. Further, we 33 
update the temporal trends of pruritus, as well as gastroenteric and respiratory disease, using as 34 
baseline the data from April 2016 to April 2018. The final section summarises some recent 35 
developments pertinent to companion animal health, namely Salmonellosis in cats in Sweden and the 36 
United States of America (USA) and Campylobacter in dogs in the USA. We also present a clinical 37 
summary on Pseudomonas otitis infections in cats and dogs in the UK. 38 
Key words: disease surveillance, pruritus, pseudomonas, skin, otitis, fluoroquinolone 39 
 40 
1. Syndromic surveillance of pruritus  41 
The skin can be a marker of general health. In companion animals, most skin lesions occur due to 42 
diseases primarily affecting the skin, however, some reflect important systemic disease. Pruritus is a 43 
common clinical sign, often because of hypersensitivities and infectious dermatoses, but occasionally 44 
due to underlined systemic disease. Therefore, early recognition of skin lesions and pruritus can 45 
maximise patient outcomes (Vogelnest, 2017).  46 
This report used electronic health records (EHRs) collected between January and April 2018 for 341044 47 
consultations including 98 979 from cats (29 per cent) and 242 065 from dogs (71 per cent), and using 48 
the main presenting complaint (MPC) recorded by practitioners for each booked consultation within 49 
the SAVSNET network. Presentation with pruritus, comprised 2.2 per cent of cat (n=2195) and 3.8 per 50 
cent of dog consultations (n=9249). Compared to our previous report on pruritus from 2016,  in 2018 51 
we observed a decrease of the percentage of consultations for pruritus in both cats and dogs (3.6 in 52 
cats and 6.5 in dogs, respectively, between January 2014 and June 2016) (Sánchez-Vizcaíno et al., 53 
2016). 54 
Veterinary practitioners’ participating in SAVSNET also completed short questionnaires for 435 cats 55 
and 1981 dogs, randomly selected from the consultations where the main complaint was pruritus. 56 
Based on this questionnaire, the most common location of the pruritus in cats was the dorsal body 57 
(27 per cent) and in dogs, the ears (37 per cent) (Table 1A). Overall, 43 per cent of the cats and 45 per 58 
cent of the dogs had pruritus for less than a month. However, in 14 per cent of the cats and dogs, the 59 
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pruritus had a duration between 3 months and one year, and in 19 per cent of the cats and 21 per 60 
cent of the dogs, the pruritus was recorded as being over one year in duration.  61 
The most commonly prescribed medications against pruritus in cats were systemic-glucocorticoids 62 
and anti-parasitic drugs (35 and 22 per cent, respectively). In contrast, in dogs the most commonly 63 
prescribed medications were topical-antimicrobials and topical-glucocorticoids (22 and 17 per cent, 64 
respectively) (Table 1B). 65 
2. Spatial distribution of pruritus 66 
We calculated the percentage of consultations for pruritus from April 2017 to April 2018 in each 10 67 
km gridded cell for those areas of GB where the SAVSNET collects data.  We used the results from the 68 
2016 surveillance report on pruritus (3.6 per cent of the cat and 6.5 per cent of the dog consultations), 69 
to set a threshold for increased risk of pruritus per 10 km gridded cell (Sánchez-Vizcaíno et al., 2016). 70 
We graded the spatial "risk" for pruritus as:  71 
i) Low, if the proportion of pruritus consultations was less than 75 per cent of this threshold (<2.7 per 72 
cent for cats, <4.9 per cent for dogs);  73 
ii) Average, if the proportion of pruritus consultations was within 25 per cent of this threshold (2.7-4.5 74 
per cent for cats and 4.9-8.1 per cent for dogs); and  75 
iii) High, if the proportion of pruritus consultations was greater than 25 per cent above the threshold 76 
(>4.5 per cent for cats and >8.1 per cent for dogs).  77 
Figure 1 shows the distribution of the spatial risk for pruritus for each season from April 2017 to April 78 
2018. Overall, and in all seasons, the most common risk category for pruritus was low (47 per cent to 79 
49 percent of the area grids covered by SAVSNET for cats, and 49 per cent to 52 per cent in dogs). In 80 
cats, cells deemed high risk were a slightly more frequent in spring and summer (24 per cent and 23 81 
per cent of the areas where SAVSNET is present), compared to autumn and winter (22 per cent and 82 
20 per cent). In dogs, 20 percent of the areas where SAVSNET is present had a proportion of 83 
consultations for pruritus above the threshold both in summer, autumn and winter, compared to 17 84 
per cent in spring (category “high” risk in Figure 1).  The majority of areas with a high proportion of 85 
consultations for pruritus in cats and dogs, across all seasons, appeared to be in urban areas and closer 86 
to the coast. SAVSNET intends to investigate further the risk factors for increased risk of pruritus. The 87 
technical specification and code used to reproduce these data are available from the authors on 88 
request. 89 
 Laboratory-based investigation of Pseudomonas aeruginosa infections in companion animals 90 
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Bacterial culture and phenotypic antimicrobial susceptibility data produced between 2011 and 2017 91 
(inclusive) was summarised from four veterinary diagnostic laboratories. Pseudomonas aeruginosa 92 
antimicrobial susceptibility data was available from 37,673 clinical canine isolates, and 1,830 clinical 93 
feline isolates. For isolates where a sampling site was recorded (98.7 per cent of canine isolates, and 94 
97.0 per cent of feline isolates), the ear was the most commonly recorded site for dogs, encompassing 95 
71.0 per cent (95 per cent credible interval, CI, 70.6-71.5, n=26,772) of P. aeruginosa isolates. 96 
Conversely, for cats P. aeruginosa was most commonly isolated and susceptibility tested from 97 
oronasal samples, encompassing 36.6 per cent (CI 34.4-38.8, n=670) of P. aeruginosa isolates. 98 
Comparatively, ear samples comprised 13.9 per cent (CI 12.3-15.5, n=255) of feline isolates, and 99 
oronasal samples 5.3 per cent (CI 5.0-5.5, n=97) of canine isolates.  100 
Different protocols and interpretation guidelines were utilised between laboratories contributing data 101 
to this dataset; hence, results should be interpreted with some caution. Due to a wide variety of 102 
antimicrobials tested, results were summarised to class-level, with 'intermediate' results being 103 
interpreted as being sensitive to the antimicrobial in question. For dogs, 65.4 per cent (CI 64.8-66.0) 104 
of P. aeruginosa isolates were sensitive to all tested antimicrobials; 30.6 per cent (CI 30.1-31.2) were 105 
resistant to one or two antimicrobial classes, and 4.0 per cent (CI 3.7-4.2) resistant to three or more 106 
antimicrobial classes (hence, 'multi-drug resistant'). For cats, 72.6 per cent (CI 67.1-78.0) of isolates 107 
were sensitive to all tested antimicrobials; 23.1 per cent (CI 18.0-28.3) resistant to one or two 108 
antimicrobial classes, and 4.3 per cent (CI 1.8-6.8) were deemed multi-drug resistant. Five canine 109 
isolates were found to be resistant to all tested antimicrobials; no such isolates were found in cats.  110 
Table 2 displays a summary of antimicrobial class-level resistance in dogs and cats. Tested isolates 111 
were most commonly resistant to fluoroquinolones in both dogs (25.0 per cent of tested isolates, CI 112 
24.5-25.5) and cats (17.7 per cent of tested isolates, CI 13.0-22.3), consistent with a previous canine 113 
survey (Martín Barrasa et al., 2000). Figure 2 shows the percentage of tested isolates displaying 114 
phenotypic fluoroquinolone resistance by year (2011-2017), suggesting a slight, but inconsistent, 115 
decrease in P. aeruginosa resistance incidence in this period for these canine ear clinical isolates.  116 
Though rare, phenotypic carbapenem resistance was observed in this sample. Although carbapenems 117 
are rarely (if ever) prescribed to companion animals in the UK (Buckland et al., 2016; Singleton et al., 118 
2017), previous research has suggested that fluoroquinolone use might co-select for carbapenem 119 
resistance of relevance to both animal and human health (Haenni et al., 2017). Resistance to 120 
aminoglycosides or polymixins classes, commonly indicated as appropriate first-line otitis therapies, 121 
was relatively uncommon in this population. It should be noted however that phenotypic susceptibility 122 
tests are not reliable indicators for predicting topical antimicrobial therapy success. 123 
3. Update on the temporal trends of the main syndromes in companion animals  124 
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The observed prevalence time series for three key MPCs, pruritus, gastroenteric and respiratory 125 
disease from April 2016 to April 2018 are shown in Figure 3, together with a seasonal trend line (dark 126 
grey line).  The trend line was calculated using a Bayesian Binomial generalised linear model with a 127 
linear trend accounting for known reporting bias over time, and a periodic Gaussian process capturing 128 
seasonal temporal correlation and over-dispersion in a data-determined way (Rasmussen and 129 
Williams, 2006). The model was trained on observed weekly prevalence from 2014 to 2018 to calculate 130 
a smoothed prevalence trend line summarised as 95% and 99% credible intervals, CI (light grey 131 
shading). Extreme prevalence observations are highlighted in orange (tail probability between 1% and 132 
5%) and red (tail probability less than 1%). The technical specification and code used to reproduce 133 
these data is available from the authors on request. 134 
These results show that many weeks in 2018, as indicated by red and orange points in Figure 3, had 135 
an unusually high prevalence of gastroenteritis in cats and respiratory disease in both species, relative 136 
to what would be expected given the previous three years of observations.  These results also highlight 137 
seasonal prevalence fluctuations in all cases, the shape of which is clearly specific to the MPC in either 138 
species.  For example, in dogs, pruritus peaks in August, gastroenteritis in February, and respiratory 139 
disease in September, whereas in cats pruritus also peaks in August, with less distinct seasonality for 140 
the other two MPCs.   141 
4. Global perspective 142 
Salmonellosis in cats in Sweden and United States of America (USA). Two separate outbreaks remind 143 
of the importance of salmonella in certain groups of cats. The Swedish Veterinary Medicine Agency 144 
(SVA) reported unusually high numbers of cats testing positive for salmonella during the first few 145 
months of 2018. The likely source of infection was wild birds. In addition, about 10 people, the 146 
majority children of pre-school age, had also been infected with similar Salmonella types, and in some 147 
cases, there was a confirmed connection to cats with salmonellosis. Separately in the USA, a batch of 148 
a commercial raw food was withdrawn after it was identified as a source of a salmonella outbreak in 149 
cats, in which two kittens died. People are reminded of the need for hygiene around garden bird 150 
feeders, and also around the use and preparation of raw feeds (Arsevska et al., 2017).  151 
Campylobacter in dogs in the USA. The United States Centre for Disease Control (CDC) investigated 152 
an outbreak of human campylobacter infection involving 113 patients, from 17 states and 23 153 
hospitalisations since 2016. The vast majority of patients reported having contact with puppies in the 154 
week before disease, particularly those coming from one pet store chain. Almost one quarter of 155 
affected humans worked in the same pet store chain. Sequence analysis of isolates from cases and in-156 
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contact puppies showed they shared the same bacterial strain, although there was no description of 157 
the precise species involved. The involved campylobacter isolate was also multidrug resistant.  158 
Dogs, especially younger dogs, are known to frequently carry campylobacter (Parsons et al., 2010). 159 
The major species carried by dogs (C. upasliensis) differs from that most frequently implicated in 160 
human disease (C. jejuni). However, this outbreak is a reminder of the potential for dogs and puppies 161 
to carry zoonotic campylobacter. The CDC also highlighted the need for responsible use of antibiotics 162 
in pets. More information at: https://www.cdc.gov/campylobacter/outbreaks/puppies-9-163 
17/index.html 164 
5. Conclusion 165 
This is the sixth Small Animal Disease Surveillance report. We highlight the importance of pruritus in GB 166 
companion animals, and in particular infection with Pseudomonas due to its potentially severe nature 167 
and zoonotic potential. Researchers can contact the authors to access the anonymised data for research 168 
purposes. SAVSNET welcomes your feedback. 169 
Update on Pseudomonas otitis in companion animals 
The organism. Pseudomonas spp. are gram-negative rod-shaped bacteria. They are ubiquitous in 
nature, particularly in aquatic habitats such as water, but also soil, decaying vegetation and on 
animals. Pseudomonas aeruginosa, the most clinically significant member of the family, is not a 
commensal of the normal canine ear but is an opportunistic pathogen. Colonisation of the skin 
occurs when trauma or infection destroys the fibronectin coat surrounding host cells. This is 
common in immunocompromised animals or in cases where chronic antibiotic therapy has 
destroyed normal bacterial flora. The pathogenicity of Pseudomonas is dependent upon the 
presence of virulence factors such as elaborated toxins, adhesins on the outer membrane that form 
part of the fimbriae responsible for binding to host proteins, and the outer polysaccharide capsule 
which protects the bacteria from immune attack. 
Pseudomonas spp. are common pathogens in cases of canine otitis externa, particularly in chronic 
disease. Infection never occurs in a normal ear and is always secondary to an underlying primary 
cause, notably allergy, endocrine disease and the presence of hyperplastic or neoplastic lesions 
within the ear canal. In ear disease in man, Pseudomonas infection is associated with exposure of 
the ear canal to water. In dogs, genetic homology between otic and environmental isolates is 
consistent with a waterborne source of infection for some dogs, and cross contamination with other 
humans and animal members within some households for others. 
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Diagnosis. The diagnosis of Pseudomonas otitis is made based on history, clinical signs, otoscopic 
examination, otic cytology and confirmatory culture and susceptibility. Typically, the ear is painful 
rather than pruritic, due to ear canal ulceration, oedema and hyperplasia. The discharge is generally 
muco-purulent, haemorrhagic and malodorous. Most P. aeruginosa strains produce one or more 
pigments, including pyocyanin that gives the discharge a green-yellow colour. Despite this quite 
characteristic appearance, veterinarians should still perform cytology on every case to help 
establish the type of infection involved. A sample of discharge can be taken for cytology from the 
junction of the horizontal and vertical canal using a cotton swab, rolled onto a glass slide, heat fixed 
and stained using a modified Romanowsky-type stain (modified Wright’s stain or DiffQuik). The 
presence of rods with an inflammatory infiltrate is significant but not definitive for Pseudomonas 
spp., as both gram positive and gram-negative bacilli appear blue with this stain. A bacterial culture 
is essential for speciation, together with antimicrobial susceptibility to help determine appropriate 
therapy. 
Treatment. The two most important factors in the therapy for Pseudomonas otitis are thorough ear 
cleaning and the selection of suitable antimicrobial drugs. Ear cleaning is useful to break up the 
mucoid discharge and allow increased contact of antimicrobial agents with the ear canal epithelium. 
Many ear cleaners, especially those that contain lactic acid, acetic acid or chlorhexidine, also have 
antimicrobial activity against Pseudomonas spp.  
Edetate disodium dehydrate (EDTA), enhanced by a tromethamine (tris) buffer, acts to damage the 
walls of gram negative bacteria such as Pseudomonas spp. Products that contain tris EDTA have 
been shown to potentiate the activity of antibiotics such as aminoglycosides, making them 
important components of any treatment regime for Pseudomonas otitis. More than 40% of otic P. 
aeruginosa isolates are biofilm-producing organisms. As such, these sessile bacteria are likely to be 
more resistant to antibiotics than their planktonic counterparts. Clinical studies have shown that 
topical otic antibiotics reach levels 100-1000 times higher compared to the antibiotics given 
systemically, making this the route of choice for drug administration. Responsible antibiotic usage 
dictates licensed products containing aminoglycoside (framycetin and gentamicin) and polymyxin B 
should be first choice antibiotics where appropriate. Veterinarians can use licensed products 
containing fluoroquinolones (marbofloxacin, orbifloxacin) where sensitivity is confirmed and where 
resistance exists to first line drugs. Other antibiotics, which constitute an off licensed use of topical 
medication should be reserved for severe cases with compromised animal welfare and where no 
other medication appears suitable based on culture and susceptibility. 
Further reading: 
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NUTTALL, T., COLE, L.K. Evidence-based veterinary dermatology: a systemic review of interventions 
for the treatment of Pseudomonas otitis in dogs. (2007) Vet Dermatol, 18,2 69-77 
 
PATERSON, S., WATYSKIEWICZ, W. (2018) A study to evaluate the primary causes associated with 
Pseudomonas otitis in 60 dogs. Journal of Small Animal Practice. 59, 4 238-242 
 
PYE, C.C., YU, A.A., WEESE, J.S. (2013) Evaluation of biofilms production by Pseudomonas 
aeruginosa from canine ears and the impact of biofilm on antimicrobial susceptibility in vitro Vet 
Dermatol 24, 2 446-9   
 
PYE, C.C., SINGH, A., WEESE, J.S. (2014) Evaluation of the impact of tromethamine edetate disodium 
dehydrate on antimicrobial susceptibility of Pseudomonas aeruginosa in biofilm in vitro. Vet 
Dermatol. 24, 2 120-4  
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Tables 
Tables 1A and 1B: Number and percentage of cats and dogs* with pruritus. A. main anatomical part 
affected, B. main treatment prescribed. Results are for randomly selected animals visiting the 
SAVSNET veterinary premises in the Great Britain, from January 2018 to April 2018.  
A. 
Anatomical part Cat* Dog* 
Dorsal body 205 (27%) 337 (10%) 
Ears 104 (14%) 1206 (37%) 
Face 130 (17%) 310 (9%) 
Feet/limbs 56 (7%) 585 (18%) 
Tail 110 (15%) 259 (8%) 
Ventral body 115 (15%) 439 (13%) 
Other 36 (5%) 160 (5%) 
Sum 756 (100%) 3296 (100%) 
 
B. 
Treatment Cat* Dog* 
Systemic-antimicrobial 89 (12%) 325 (8%) 
Systemic-glucocorticoid 257 (35%) 469 (12%) 
Topical-antimicrobial 64 (9%) 843 (22%) 
Topical-glucocorticoid 51 (7%) 656 (17%) 
Anti-parasitic 158 (22%) 164 (4%) 
Ear-cleaner 18 (2%) 384 (10%) 
Shampoo 6 (1%) 215 (6%) 
Other 57 (8%) 595 (15%) 
None 24 (3%) 177 (5%) 
Sum 724 (100%) 3828 (100%) 
 
* The same animal could present with more than one clinical sign per consultation. The same animal can also 
have more than one administered treatment per consultation. 
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Table 2: Number and percentage of canine and feline Pseudomonas aeruginosa clinical isolates 
originally isolated from ear samples tested as being resistant to a number of antimicrobial classes. 
Data originates from four UK-based veterinary diagnostic laboratories, recorder between 2011 and 
2017 (inclusive). 95% CI = 95% credible interval. 
Antimicrobial class Canine  Feline  
 Number of 
isolates tested 
Percentage 
resistant (95% CI) 
Number of 
isolates tested 
Percentage 
resistant (95% CI) 
Aminoglycosides 26772 8.4  
(8.1-8.7) 
255 5.1  
(2.4-7.8) 
Amphenicols 584 2.1  
(2.0-2.3) 
6 2.4  
(0.5-4.2) 
Carbapenems 4421 0.2  
(0.1-0.2) 
46 1.2  
(0-2.5) 
Extended-spectrum 
penicillins 
14355 3.6  
(3.4-3.8) 
140 4.3  
(1.8-6.8) 
First- / second-generation 
cephalosporins 
868 3.2  
(3.0-3.4) 
10 3.9  
(1.5-6.3) 
Fluoroquinolones 26769 25.0  
(24.5-25.5) 
255 17.7  
(13.0-22.3) 
Fusidic acid 1000 3.7  
(3.5-4.0) 
9 3.5  
(1.3-5.8) 
Lincosamides 67 0.2  
(0.2-0.3) 
2 0.8  
(0-1.9) 
Macrolides 64 0.2  
(0.2-0.3) 
2 0.8  
(0-1.9) 
Narrow-spectrum 
penicllins 
9 0.0  
(0.0-0.0) 
0 NA 
Nitrofurantoin 2 0.0  
(0.0-0.0) 
0 NA 
Polymixins 26531 1.3  
(1.2-1.4) 
252 2.4  
(0.5-4.2) 
Potentiated penicillins 959 3.4  
(3.2-3.7) 
9 3.5  
(1.3-5.8) 
Potentiated 
sulphonamide 
151 0.5  
(0.4-0.6) 
3 1.2  
(0-2.5) 
Tetracyclines 40 0.1  
(0.1-0.2) 
0 NA 
Third- / fourth-generation 
cephalosporins 
578 0.2  
(0.1-0.2) 
3 0.0  
(0.0-0.0) 
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Figures 
 
 
FIG 1: Spatial risk for pruritus in cats and dogs in Great Britain, from April 2017 to April 2018. The 
spatial risk has been categorised as low, average and high, and calculated based on a threshold set by 
the average percentage of consultations for pruritus from 2014 to 2016 (Sánchez-Vizcaíno et al., 
2016).  
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FIG 2: Summary of the percentage of tested Pseudomonas aeruginosa isolates originally isolated from 
canine and feline clinical samples displaying phenotypic fluoroquinolone resistance by year (2011-
2017). Data summarised from four veterinary diagnostic laboratories.
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FIG 3: Observed prevalence for pruritus, gastroenteric and respiratory disease in cats and dogs 
attending SAVSNET-participating practices from April 2016 to April 2018 and predicted trends for May 
2018. Red points represent the extreme outliers (outside the 99% credible interval, CI), orange points 
represent the moderate outliers (outside the 95% CI but within the 99% CI), and green points 
represent the average trend (within the 95 % CI).  
 
 
